| Absolute scale of second-order nonlinear-optical coefficients I Shoji, T Kondo, A Kitamoto, M Shirane, R Ito JOSA B 14 (9), 2268-2294, 1997 | 1004 | 1997 |
| Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2 T Kondo, MP Bobek, R Kuick, B Lamb, X Zhu, A Narayan, D Bourc’his, ... Human Molecular Genetics 9 (4), 597-604, 2000 | 203 | 2000 |
| Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for … T Kondo, S Hirohashi Nature protocols 1 (6), 2940-2956, 2006 | 191 | 2006 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 181 | 2018 |
| Plasma proteomics of lung cancer by a linkage of multi‐dimensional liquid chromatography and two‐dimensional difference gel electrophoresis T Okano, T Kondo, T Kakisaka, K Fujii, M Yamada, H Kato, T Nishimura, ... Proteomics 6 (13), 3938-3948, 2006 | 174 | 2006 |
| Application of sensitive fluorescent dyes in linkage of laser microdissection and two‐dimensional gel electrophoresis as a cancer proteomic study tool T Kondo, M Seike, Y Mori, K Fujii, T Yamada, S Hirohashi Proteomics 3 (9), 1758-1766, 2003 | 164 | 2003 |
| Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of … T Kakisaka, T Kondo, T Okano, K Fujii, K Honda, M Endo, A Tsuchida, ... Journal of Chromatography B 852 (1-2), 257-267, 2007 | 150 | 2007 |
| Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer H Hatakeyama, T Kondo, K Fujii, Y Nakanishi, H Kato, S Fukuda, ... Proteomics 6 (23), 6300-6316, 2006 | 132 | 2006 |
| Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features T Shibata, S Uryu, A Kokubu, F Hosoda, M Ohki, T Sakiyama, Y Matsuno, ... Clinical Cancer Research 11 (17), 6177-6185, 2005 | 128 | 2005 |
| Proteomic study of human hepatocellular carcinoma using two‐dimensional difference gel electrophoresis with saturation cysteine dye K Fujii, T Kondo, H Yokoo, T Yamada, K Iwatsuki, S Hirohashi Proteomics 5 (5), 1411-1422, 2005 | 115 | 2005 |
| Suppression of Intestinal Polyposis in Mdr1-deficient ApcMin/+ Mice T Yamada, Y Mori, R Hayashi, M Takada, Y Ino, Y Naishiro, T Kondo, ... Cancer research 63 (5), 895-901, 2003 | 115 | 2003 |
| Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness C Huang, G Ding, C Gu, J Zhou, M Kuang, Y Ji, Y He, T Kondo, J Fan Clinical Cancer Research 18 (11), 3042-3053, 2012 | 112 | 2012 |
| Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells H Yokoo, T Kondo, K Fujii, T Yamada, S Todo, S Hirohashi Hepatology 40 (3), 609-617, 2004 | 108 | 2004 |
| Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics Y Suehara, T Kondo, K Seki, T Shibata, K Fujii, M Gotoh, T Hasegawa, ... Clinical Cancer Research 14 (6), 1707-1717, 2008 | 104 | 2008 |
| Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end‐binding protein 1 in hepatocellular carcinoma T Orimo, H Ojima, N Hiraoka, S Saito, T Kosuge, T Kakisaka, H Yokoo, ... Hepatology 48 (6), 1851-1863, 2008 | 97 | 2008 |
| Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome H Katoh, T Shibata, A Kokubu, H Ojima, P Loukopoulos, Y Kanai, ... Journal of hepatology 43 (5), 863-874, 2005 | 95 | 2005 |
| Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets H Katoh, H Ojima, A Kokubu, S Saito, T Kondo, T Kosuge, F Hosoda, ... Gastroenterology 133 (5), 1475-1486, 2007 | 92 | 2007 |
| Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics N Uemura, Y Nakanishi, H Kato, S Saito, M Nagino, S Hirohashi, T Kondo International Journal of Cancer 124 (9), 2106-2115, 2009 | 89 | 2009 |
| In vitro attenuation of highly virulent infectious bursal disease virus: some characteristics of attenuated strains T Yamaguchi, T Kondo, Y Inoshima, M Ogawa, M Miyoshi, T Yanai, ... Avian Diseases, 501-509, 1996 | 85 | 1996 |
| Proteomic signatures corresponding to histological classification and grading of soft‐tissue sarcomas Y Suehara, T Kondo, K Fujii, T Hasegawa, A Kawai, K Seki, Y Beppu, ... Proteomics 6 (15), 4402-4409, 2006 | 84 | 2006 |
